Aspiriant LLC Portfolio holdings
Top Buys
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$106M |
| 2 |
WisdomTree Europe Hedged Equity Fund
HEDJ
|
+$11.9M |
| 3 |
Xtrackers MSCI All World ex US Hedged Equity ETF
DBAW
|
+$7M |
| 4 |
SPDR Gold Trust
GLD
|
+$6.5M |
| 5 |
iShares MSCI Global Min Vol Factor ETF
ACWV
|
+$5.6M |
Top Sells
Sector Composition
| 1 | Financials | 4.36% |
| 2 | Technology | 2.26% |
| 3 | Healthcare | 2.08% |
| 4 | Industrials | 1.5% |
| 5 | Communication Services | 1.43% |
Similar funds
Aspiriant LLC's Q2 2016 Portfolio in Review
As of Q2 2016, Aspiriant LLC held 195 positions worth $1.06B, up 1% from $1.05B the previous quarter. Its ten largest holdings account for 59% of the portfolio.
Aspiriant LLC deployed $35.4M of net new capital in Q2 2016, opening 28 new positions and adding to 57 existing holdings. Its largest new stake was WisdomTree Europe Hedged Equity Fund: 458,044 shares worth $12.7M.
By sector, the portfolio is most concentrated in Financials at 4.4% of assets, down from 4.4% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $18.2M trimmed.
- Aspiriant LLC's largest Q2 2016 buy was WisdomTree Europe Hedged Equity Fund: 458,044 shares worth $12.7M.
- Aspiriant LLC added most to Berkshire Hathaway Class A in Q2 2016, an estimated $106M increase.
- Aspiriant LLC's biggest Q2 2016 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $18.2M.
- Aspiriant LLC fully exited Xtrackers MSCI Europe Hedged Equity ETF in Q2 2016, selling an estimated $10.8M.
- Aspiriant LLC's ten largest holdings make up 59% of its $1.06B portfolio in Q2 2016.
- Aspiriant LLC opened 28 new positions and closed 17 in Q2 2016.
- Aspiriant LLC's portfolio value rose 1% quarter-over-quarter to $1.06B.
Based on Aspiriant LLC's 13F filing for Q2 2016, filed 9 Aug 2016.